Inter-Individual Variability in Metabolic Syndrome Severity Score and VO2max Changes Following Personalized, Community-Based Exercise Programming.
Sophie SewardJoyce RamosClaire DrummondAngela DalleckBryant ByrdMackenzie KehmeierLance C DalleckPublished in: International journal of environmental research and public health (2019)
This study sought to examine the effectiveness of a personalized, community-based exercise program at reducing MetS severity and consequently Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) risk. One-hundred and fifty physically inactive participants (aged 18-83 years) were randomized to a non-exercise control group (n = 75; instructed to continue their usual lifestyle habits) or treatment group (n = 75). Participants randomized to the treatment group completed a 12 week personalized exercise training program based on the American Council on Exercise (ACE) Integrated Fitness Training (IFT) model guidelines. Z-scores were derived from levels of metabolic syndrome risk factors to determine the severity of MetS (MetS z-score). After 12 weeks, the treatment group showed a significant favorable change in MetS z-score, whereas the control group demonstrated increased severity of the syndrome (between-group difference, p < 0.05). The proportion of MetS z-score responders (Δ > -0.48) was greater following the exercise intervention (71%, 50/70) compared to control (10%, 7/72) (between group difference, p < 0.001). The inter-individual variability in VO2max change also showed a similar trend. These findings provide critical translational evidence demonstrating that personalized exercise programming based upon the ACE IFT model guidelines can be successfully implemented within the community setting to reduce T2DM and CVD risk.
Keyphrases
- high intensity
- physical activity
- metabolic syndrome
- cardiovascular disease
- resistance training
- risk factors
- double blind
- systematic review
- body composition
- insulin resistance
- open label
- clinical trial
- cardiovascular risk factors
- mental health
- quality improvement
- uric acid
- phase ii
- adipose tissue
- clinical practice
- phase iii
- angiotensin converting enzyme
- study protocol